These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31161560)

  • 1. Development of a metabolic syndrome severity score and its association with incident diabetes in an Asian population-results from a longitudinal cohort in Singapore.
    Low S; Khoo KCJ; Wang J; Irwan B; Sum CF; Subramaniam T; Lim SC; Wong TKM
    Endocrine; 2019 Jul; 65(1):73-80. PubMed ID: 31161560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Metabolic Syndrome Severity
    DeBoer MD; Filipp SL; Gurka MJ
    Diabetes Care; 2018 Nov; 41(11):2421-2430. PubMed ID: 30275282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.
    Gurka MJ; Guo Y; Filipp SL; DeBoer MD
    Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of BMI as the marker of adiposity in a metabolic syndrome severity score: Derivation and validation in predicting long-term disease outcomes.
    Gurka MJ; Filipp SL; Musani SK; Sims M; DeBoer MD
    Metabolism; 2018 Jun; 83():68-74. PubMed ID: 29410278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores.
    Gurka MJ; Filipp SL; Pearson TA; DeBoer MD
    J Am Heart Assoc; 2018 Aug; 7(16):e009754. PubMed ID: 30369320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
    Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
    Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
    Ding C; Yang Z; Wang S; Sun F; Zhan S
    Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent association of metabolic syndrome severity score and risk of diabetes: findings from 18 years of follow-up in the Tehran Lipid and Glucose Study.
    Amouzegar A; Honarvar M; Masoumi S; Agahi S; Azizi F; Mehran L
    BMJ Open; 2024 Sep; 14(9):e078701. PubMed ID: 39260837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study.
    Hadaegh F; Abdi A; Kohansal K; Hadaegh P; Azizi F; Tohidi M
    Front Endocrinol (Lausanne); 2023; 14():1164771. PubMed ID: 37305040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a chinese population with high postprandial glucose.
    Wang JJ; Qiao Q; Miettinen ME; Lappalainen J; Hu G; Tuomilehto J
    Diabetes Care; 2004 Oct; 27(10):2429-37. PubMed ID: 15451912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and risk of major coronary events among the urban diabetic patients: North Indian Diabetes and Cardiovascular Disease Study-NIDCVD-2.
    Bhatti GK; Bhadada SK; Vijayvergiya R; Mastana SS; Bhatti JS
    J Diabetes Complications; 2016; 30(1):72-8. PubMed ID: 26271411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome predicts incident congestive heart failure: a 20-year follow-up study of elderly Finns.
    Wang J; Sarnola K; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Atherosclerosis; 2010 May; 210(1):237-42. PubMed ID: 19945701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity.
    DeBoer MD; Filipp SL; Sims M; Musani SK; Gurka MJ
    Stroke; 2020 Aug; 51(8):2548-2552. PubMed ID: 32552367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between metabolic syndrome severity score and cardiovascular disease: results from a longitudinal cohort study on Chinese adults.
    Lin JJ; Dai PY; Zhang J; Guan YQ; Gong WW; Yu M; Fang L; Hu RY; He QF; Li N; Wang LX; Liang MB; Zhong JM
    Front Endocrinol (Lausanne); 2024; 15():1341546. PubMed ID: 38654930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score.
    Gurka MJ; Lilly CL; Oliver MN; DeBoer MD
    Metabolism; 2014 Feb; 63(2):218-25. PubMed ID: 24290837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
    Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
    J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of metabolic syndrome score by confirmatory factor analysis in children and adults and prediction of cardiometabolic outcomes in adults.
    Viitasalo A; Lakka TA; Laaksonen DE; Savonen K; Lakka HM; Hassinen M; Komulainen P; Tompuri T; Kurl S; Laukkanen JA; Rauramaa R
    Diabetologia; 2014 May; 57(5):940-9. PubMed ID: 24463933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).
    Gagnon C; Lu ZX; Magliano DJ; Dunstan DW; Shaw JE; Zimmet PZ; Sikaris K; Ebeling PR; Daly RM
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1953-61. PubMed ID: 22442263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.